Supplementary Figure 3 from Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models
Fabian F. Pusch,Heathcliff Dorado García, Robin Xu,Dennis Gürgen,Yi Bei,Lotte Brückner,Claudia Röefzaad,Jennifer von Stebut,Victor Bardinet, Rocío Chamorro Gonzalez,Angelika Eggert,Johannes H. Schulte, Patrick Hundsdörfer,Georg Seifert,Kerstin Haase,Beat W. Schäfer,Marco Wachtel,Anja A. Kühl,Michael V. Ortiz,Antje M. Wengner,Monika Scheer,Anton G. Henssen crossref（2024）
摘要
Supplementary Figure 3 shows western blots of DNA damage response markers in two pediatric cancer cell lines.
查看译文
AI 理解论文
溯源树
样例
